ZRT LABORATORY, LLC

Beaverton, OR · Medtech · Private

Dried blood spot (DBS) diagnostic test measuring neuroendocrine biomarkers (GABA, allopregnanolone, glutamate, serotonin, kynurenine) to predict ADHD treatment response

zrtlab.com →
Grants
$256K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$92K
1 award · Health and Human S
#534 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · TAS::75 0943::TAS 00HCUCJB-2010-86227 - 25-HYDROXYVITAMIN D Serum Deficiency$92,080
Federal grantDepartment of Health and Human Services · Phase I · A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD.$201,392
Federal grantDepartment of Health and Human Services · Phase I · A Dried Blood Spot Companion Diagnostic to Measure Neuroendocrine Changes in ADHD.$55,000
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
531Zalgen Labs$97K—
532SONITUS MEDICAL INC$97K$58M
533Golden Helix, Inc.$93K—
534ZRT LABORATORY, LLC$92K—
535SYNTERMED INCORPORATED$88K—
536BIOSENSE TECHNOLOGIES, INC.$86K—
537ALLELE DIAGNOSTICS INC$84K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.